Description
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
Product Unit Size | Cost | Quantity | Stock |
---|
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
Cas No. | 1096708-71-2 |
---|---|
Purity | ≥98% |
Formula | C17H12Cl2F3N7O2S |
Formula Wt. | 506.30 |
IUPAC Name | 2-[(1R)-1-[(6-amino-5-chloropyrimidine-4-carbonyl)amino]ethyl]-N-[5- chloro-4-(trifluoromethyl)pyridin-2-yl]-1,3-thiazole-5-carboxamide |
Solubility | DMSO 100 mg/mL (197.51 mM) Ethanol 100 mg/mL (197.51 mM) Water Insoluble |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet | |
Brochures |
http://clinicaltrials.gov/show/NCT01425008
Monoterpene found in various plant sources.
PAK4 inhibitor.
BHA derivative.
Dicarboxylic acid found in Arabidopsis; PPARγ ...
Protease inhibitor.
Hexokinase inhibitor, aerobic glycolysis inhibi...
Endogenous peptide hormone fragment, involved i...
p110γ PI3K inhibitor.
Antipruritic.
Optically active cysteine derivative found in A...
Mycotoxin metabolite
JAK2 inhibitor.
TRPC5, NS4B, histamine H1 inhibitor.
Pneumonia antigen
MET inhibitor.
Peptide; galanin antagonist.
Endogenous neuropeptide hormone; somatostatin a...
Prodrug
BRD2/4/9 and CECR2 inhibitor.
14-α demethylase inhibitor.